Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.835
+0.145 (5.39%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Cellectis Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -65.31 | -67.59 | -36.76 | -108.44 | -114.03 | -125.11 |
Depreciation & Amortization | 19.06 | 20.06 | 19.85 | 18.52 | 18.44 | 14.16 |
Stock-Based Compensation | 7.8 | 6.11 | 3.17 | 5.23 | 6.04 | 11.49 |
Other Adjustments | 0.66 | 35.19 | -23.48 | 19.49 | 9.93 | -4.42 |
Change in Receivables | 0.26 | -9.45 | 45.86 | -3.99 | -8.99 | -12.44 |
Changes in Inventories | - | - | - | - | - | 0.22 |
Changes in Accounts Payable | 2.98 | -3.26 | 2.06 | -6.31 | 3.25 | 0.18 |
Changes in Unearned Revenue | -19.64 | -28.88 | 5.75 | 59.15 | 0.02 | -0.25 |
Changes in Other Operating Activities | 4.9 | 8.42 | 6.56 | -0.02 | -17.44 | -16.75 |
Operating Cash Flow | -41.63 | -39.4 | 22.99 | -24.75 | -87.44 | -104.56 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -2.18 | -2.36 | -2.58 | -1.07 | -2.43 | -18.54 |
Purchases of Intangible Assets | - | -1.17 | -1.26 | - | -0.01 | -0.01 |
Purchases of Investments | -116.48 | -159.78 | -162.77 | -13.36 | 0.13 | -0.14 |
Proceeds from Sale of Investments | 151.21 | 133.83 | 63.81 | 0.49 | - | 15 |
Other Investing Activities | - | - | - | -1.56 | -0.45 | 10.98 |
Investing Cash Flow | 31.56 | -29.48 | -102.81 | -15.51 | -2.76 | 7.28 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 23.2 | 29.67 | 5.75 | - |
Long-Term Debt Repaid | -5.56 | -5.38 | -5 | -5.11 | -1.34 | - |
Net Long-Term Debt Issued (Repaid) | -5.56 | -5.38 | 18.2 | 24.56 | 4.41 | - |
Issuance of Common Stock | - | 0.04 | 82.82 | 67.94 | -0.57 | 56.24 |
Net Common Stock Issued (Repurchased) | - | 0.04 | 82.82 | 67.94 | -0.57 | 56.24 |
Other Financing Activities | -11.24 | -11.43 | -11.91 | -9.64 | -2.69 | -8.72 |
Financing Cash Flow | -16.55 | -16.76 | 89.11 | 81.08 | 1.15 | 47.53 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 2.4 | 3.93 | -2.75 | 0.88 | -3.36 | -5.75 |
Net Cash Flow | -26.62 | -85.65 | 9.3 | 42.61 | -89.06 | -49.76 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -43.8 | -41.76 | 20.41 | -25.82 | -89.88 | -123.11 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -68.63% | -52.47% | 41.46% | -280.85% | -349.38% | -318.95% |
Free Cash Flow Per Share | -0.43 | -0.42 | 0.23 | -0.45 | -1.97 | -2.75 |
Levered Free Cash Flow | -65.75 | -78.99 | 13.06 | -6.22 | -115.25 | -135.19 |
Unlevered Free Cash Flow | -53.18 | -39.3 | -27.93 | -26.72 | -87.76 | -124.47 |